Additional European Equity Opening News - 18th September 2026
European opening news highlighted AstraZeneca's US Priority Review, TotalEnergies' USD 1.8bln infrastructure partnership, Investec's higher profit guidance, and Wizz Air's winter capacity cuts.
News detail
AstraZeneca (AZN LN) - Co.'s Efzimfotase alfa granted Priority Review in the US as treatment for patients with hypophosphatasia aged 2 years and older. (AstraZeneca) Investec (INVP LN) - Trading Statement: Expects H1 2027 Adj. EPS between GBP 0.417-0.433/shr (prev. GBP 0.405/shr Y/Y), adj. operating PBT between GBP 479.2-496.2mln (prev. GBP 468.1mln Y/Y). (Investec) Societe Generale (GLE FP) - SocGen CEO Slawomir Krupa is expected to unveil higher profitability targets, further cost cuts and selective growth investments on 21st September, Bloomberg reports. Cuts are expected mainly in French retail banking and Ayvens, while investment may focus on trading, advisory, US expansion, data centre financing and Boursobank. Analysts expect continued emphasis on efficiency and capital discipline. (Bloomberg) TotalEnergies (TTE FP) - Co. enters into a partnership agreement with Global Infrastructure Partners relating to TotalEnergies' interests in some oil & gas infrastructure assets in Africa. In exchange for a USD 1.8bln capital contribution, TotalEnergies will pay GIP a throughput-based tariff over a period of up to 15 years. (TotalEnergies) TUI (TUI1 GY) - Co. says Lundgren will take over as Chair of the Supervisory Board, effective February 2027. (TUI) Wizz Air (WIZZ LN) - Co. CEO says the revenue environment is improving and that they are cutting capacity for the winter period. (Bloomberg TV)
Related stocks
2 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
